Medicus Pharma Ltd. (MDCXW) cash flow statement

MDCXWNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as MDCX

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026Score 5/30

$0.21+0.00 (0.00%)

Close on Oct 30, 2026Market cap $118.78MP/E –Yield –

Medicus Pharma Ltd. cash flow statement

Millions of USD, except per-share data. Shares in millions.

Line item	Q2 2026 2026-06-30	Q1 2026 2026-03-31	Q4 2025 2025-12-31	Q3 2025 2025-09-30	Q2 2025 2025-06-30	Q1 2025 2025-03-31	Q4 2024 2024-12-31	Q3 2024 2024-09-30	Q2 2024 2024-06-30	Q1 2024 2024-03-31
Stock-Based Compensation	1.41	0.60	0.43	0.85	0.12	0.11	0.09	0	0.59	0.04
Change in Accounts Payable	-0.72	0.04	-0.55	-0.95	0.77	0.30	0.12	-0.42	0.29	0.36
Operating Cash Flow	-6.98	-8.97	-6.61	-6.76	-5.47	-3.94	-3.19	-3.10	-2.78	-1.18
Investing Cash Flow	–	–	0	–	–	–	0	–	–	–
Stock Issued	0	0	0	0	6.01	3.78	0	–	–	–
Debt Issued	–	–	0	7.37	–	–	0	0	–	–
Debt Repaid	-2.35	-3.18	-1.75	-5.64	0	0	0	–	–	–
Financing Cash Flow	26	6.83	6.65	10	11	3.76	2.05	0	11	0
Foreign Exchange Rate Adjustments	0.28	-0.20	0.00	0.00	0	0	0	–	–	–
Net Change in Cash	19	-2.34	0.04	-1.01	5.69	-0.18	-1.14	–	–	–
Interest Paid	0.23	0.10	–	–	0	0	–	–	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY

Gross margin: –
Operating margin: –
Net margin: –
Return on equity, FY2025: -3083.1%

Financial strength

Current ratio: 1.57
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 140.0%

Valuation

P/E ratio: –
Price to sales: –
Price to book: –
Dividend yield: –